Changeflow GovPing Pharma & Drug Safety Percussionaire Corp Issues Phasitron 5 In-Line ...
Urgent Enforcement Amended Final

Percussionaire Corp Issues Phasitron 5 In-Line Valve Correction, Updates Use Instructions

Favicon for www.fda.gov FDA Medical Device Recalls
Filed
Detected
Email

Summary

Percussionaire Corporation issued an Urgent Medical Device Correction for the Phasitron 5 In-Line Valve (P5-TEE) due to a design limitation where leaks can occur through the pressure relief valve even when fully closed. The FDA classified this as a Class I recall, the most serious type. Leakage poses a high risk of cardiopulmonary and neurological compromise in neonatal and infant patients due to unrecognized hypoventilation, potentially causing respiratory acidosis, hypoxemia, or respiratory failure. Four serious injuries have been reported as of September 3, 2025, with no deaths.

What changed

Percussionaire Corporation corrected the Instructions for Use for the Phasitron 5 In-Line Valve (P5-TEE) to address a design limitation where leaks occur through the pressure relief valve regardless of valve position. The leakage, while often not clinically significant, can represent a substantive fraction of intended ventilation for neonatal and infant patients with small tidal volumes, creating risk of unrecognized hypoventilation.\n\nHealthcare providers using these devices for IPV therapy in line with mechanical ventilation must review and implement the updated instructions, train all primary users on the new procedures, and revise institutional protocols accordingly. Failure to follow updated instructions may cause serious injury or death, as evidenced by four reported serious injuries. Facilities should immediately contact Percussionaire at 208-263-2549 or FSCA@sentec.com with questions.

What to do next

  1. Review updated Instructions for Use for Phasitron 5 In-Line Valve
  2. Post updated instructions throughout facility and communicate changes to primary IPV therapy users
  3. Update institutional protocols related to P5-TEE in-line use to conform with new instructions

Archived snapshot

Apr 15, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.


This recall **involves updating instructions for using devices and does not involve removing them from where they are used or sold.* The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it without following the updated instructions. This recall was classified on October 14, 2025.*

Affected Product

  • Product Name: Phasitron 5 In-Line Valve
  • UDI: 00849436000723
  • Potential Lots Affected: 240326, 250116, 240418, 250324, 240610, 250616, 240620, 241121, 230612, 240826, WO04884, 241118, WO06020, 241203, WO05019, 250111, WO04827, WO04756

What to Do

On September 3, 2025, Percussionaire Corporation sent all affected customers an Urgent Medical Device Correction recommending the following actions:

  • Review the updated instructions for proper in-line use and updated Instructions for Use (IFU).
  • Print and post updated instructions for proper In-Line Valve use throughout your facility to ensure adequate distribution of new information to users.
  • Communicate and train primary users of IPV therapy, specifically those using it in line with a ventilator, on the new instructions.
  • Review institutional protocols related to P5-TEE in-line use and update as needed to conform to the updated instructions.

Reason for Correction

Percussionaire Corporation has identified a design limitation for the In-Line Valve (P5-TEE), where leaks can occur through the pressure relief valve, even if the valve is fully closed. The extent of the leak is dependent on the situation and often not clinically significant, but it can represent a substantive fraction of the intended ventilation for neonatal and infant patients with small tidal volumes. Leakage in the pressure relief valve provides a high risk of cardiopulmonary and neurological compromise due to a possibility of unrecognized hypoventilation, which could lead to respiratory acidosis, hypoxemia, or respiratory failure.

As of September 3, 2025 Percussionaire has reported four serious injuries and no deaths related to this issue.

Device Use

The IPV In-Line Valve is intended to be used to provide Intrapulmonary Percussive Ventilation (IPV) therapy to patients while assisted by Conventional Mechanical Ventilation using pressure-control, volume-control, SIMV-PC etc., when direct connection of IPV is not indicated.

Contact Information

Customers in the U.S. with questions about this recall should contact Percussionaire Corporation at 208-263-2549 or the Percussionaire/Sentec Customer Service department via email to FSCA@sentec.com.

Additional FDA Resources:

Unique Device Identifier (UDI)

The unique device identifier (UDI) helps identify individual medical devices sold in the United States from manufacturing through distribution to patient use. The UDI allows for more accurate reporting, reviewing, and analyzing of adverse event reports so that devices can be identified, and problems potentially corrected more quickly.

How do I report a problem?

Health care professionals and consumers may r eport adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program.

  • ## Content current as of:

04/15/2026

-

Named provisions

Urgent Medical Device Correction In-Line Valve (P5-TEE) Instructions for Use

Get daily alerts for FDA Medical Device Recalls

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Filed
September 3rd, 2025
Instrument
Enforcement
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
FDA Recall No. Z-2026-001
Docket
97374

Who this affects

Applies to
Medical device makers Healthcare providers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Ventilator device correction Medical device safety alert Clinical protocol update
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Healthcare Product Safety

Get alerts for this source

We'll email you when FDA Medical Device Recalls publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!